• Journal of Yeungnam Medical Science
• /
• 제33권2호
• /
• pp.125-129
• /
• 2016

Stress induced cardiomyopathy (SC) is characterized by transient left ventricular (LV) dysfunction in the absence of coronary artery disease. We report on a patient with panhypopituitarism who developed SC resulting from withdrawal of hormonal replacement therapy (HRT). A 52-year-old male visited our hospital for progressively worsening dyspnea. The patient had discontinued HRT 7 days ago, which had been administered for 18 months after transsphenoidal adenomectomy for pituitary macroadenoma. Initial electrocardiogram showed marked sinus bradycardia. Transthoracic echocardiography showed apical ballooning with an LV ejection fraction of 25%. No significant obstructive lesions were observed on coronary angiography. With a clinical diagnosis of SC associated with panhypopituitarism, HRT was restarted, including glucocorticoid and thyroxine, along with standard heart failure management. His LV function had normalized at 2-month follow-up. He remains asymptomatic and administration of beta-blocker and angiotensin converting enzyme inhibitor were discontinued He currently only requires HRT.

• Journal of Chest Surgery
• /
• 제9권2호
• /
• pp.207-214
• /
• 1976

Operations for cardiac valvular disease has been progressed in various ways. Since 1949 when Lord Russel operated mitral stenosis by closed technique at Johns Hopkins Hospital then much progress has been achieved and that nowadays severely diseased cardiac valve has been replaced by prosthetic valve, which is almost ideal in hemodynamic aspect, but still it has many problems such as thromboembolism, destruction of red blood cell, pressure gradient, and disturbance of left ventricular function, so in case of delicate situations, valve replacement should be decided carefully. Besides prosthetic valve, there are some kinds of reconstructive procedures and these have been resulted in better prognosis than prosthetic valve replacement in selected cases. So, authors have reviewed 61 Cases of cardiac patients who have been operated reconstructive valvular surgery by cardiopulmonary bypass, at Yonsei University, from Jan. 1963 to Mar. 1976. Out of 61 cases, 9 patients were replaced by prosthetic valve and rest of the patients were operated upon in various reconstructive procedures such as commissurotomy, valvotomy, valvuloplasty, and annuloplasty. Twenty cases of congenital heart diseases with valvular lesion, which had been operated for valvular lesion were also included in this statistics. Out of 9 cases of prosthetic valvular replacement five cases of prosthetic valvular replacement was done combined with other reconstructive procedures after attempted valvuloplasty. Comparative prognosis of both procedures are somewhat variable by reporters, average 19% of mortality after reconstructive surgery and 38% of mortality after prosthetic valve replacement in long term results. Most common cause of death in postoperative period was low output syndrome in both cases. It seems that good preoperative evaluation and proper reconstructive surgery will afford good prognosis in selected cardiac valvular diseased patient.

• 약학회지
• /
• 제44권6호
• /
• pp.558-565
• /
• 2000

SK-1080 is one of the newly developed orally active nonpeptide angiotensinII $AT_1-receptor$ antagonist that selectively acts at $AT_1$ receptor with high affinity. The cardiac effect on ischemia/reperfusion injury of SK-1080 was compared with those of losartan, a prototype of this class, in isolated rat hearts. Isolated perfused rat heart was pretreated with drug for 10 min and then subjected to global ischemia for 30 min followed by reperfusion with- or without drug for 30 min. The possible additive effect of SK-1080 on the platelet aggregation and coagulation in human blood was also studied. We investigated whether SK-1080 effects the platelet aggregation induced by ADP, a platelet agonist partially dependent on $thromboxaneA_2$. The clotting times in the prothrombin time (PT) and activated partial thromboplastin time (APTT) were also examined in human plasma in vitro as coagulation screening test. SK-1080 improved reperfusion function (LVDP, left ventricular developed pressure; PRP, rate-pressure product) in a dose-dependent manner. SK-1080 reduced ADP-induced platelet aggregation compared with vehicle but less than losartan, and did not affect clotting times.

• The Korean Journal of Physiology and Pharmacology
• /
• 제3권2호
• /
• pp.223-230
• /
• 1999

Alterations of cardiovascular function associated with various thyroid states have been studied. In hyperthyroidism left ventricular contractility and relaxation velocity were increased, whereas these parameters were decreased in hypothyroidism. The mechanisms for these changes have been suggested to include alterations in the expression and/or activity levels of various proteins; ${\alpha}-myosin$ heavy chain, ${\beta}-myosin$ heavy chain, ${\beta}-receptors,$ the guanine nucleotide-binding regulatory protein, and the sarcolemmal $Ca^{2+}-ATPase.$ All these cellular alterations may be associated with changes in the intracellular $Ca^{2+}$ concentration. The most important regulator of intracellular $Ca^{2+}$ concentration is the sarcoplasmic reticulum (SR), which serves as a $Ca^{2+}$ sink during relaxation and as a $Ca^{2+}$ source during contraction. The $Ca^{2+}-ATPase$ and phospholamban are the most important proteins in the SR membrane for muscle relaxation. The dephosphorylated phospholamban inhibits the SR $Ca^{2+}-ATPase$ through a direct interaction, and phosphorylation of phospholamban relieves the inhibition. In the present study, quantitative changes of $Ca^{2+}-ATPase$ and phospholamban expression and the functional consequences of these changes in various thyroid states were investigated. The effects of thyroid hormones on (1) SR $Ca^{2+}$ uptake, (2) phosphorylation levels of phospholamban, (3) SR $Ca^{2+}-ATPase$ and phospholamban protein levels, (4) phospholamban mRNA levels were examined. Our findings indicate that hyperthyroidism is associated with increases in $Ca^{2+}-ATPase$ and decreases in phospholamban levels whereas opposite changes in these proteins occur in hypothyroidism.

• 대한간학회지
• /
• 제24권4호
• /
• pp.409-416
• /
• 2018

Background/Aims: Left ventricular diastolic dysfunction (LVDD) is an early manifestation of cardiac dysfunction in patients with liver cirrhosis (LC). However, the effect of LVDD on survival has not been clarified, especially in decompensated LC. Methods: We prospectively enrolled 70 patients with decompensated LC, including ascites or variceal bleeding, at Daejeon St. Mary's Hospital from April 2013 to April 2015. The cardiac function of these patients was evaluated using 2D echocardiography with tissue Doppler imaging. The diagnosis of LVDD was based on the American Society of Echocardiography guidelines. The primary endpoint was overall survival. Results: Forty-four patients (62.9%) had LVDD. During follow-up (22.3 months), 18 patients died (16 with LVDD and 2 without LVDD). The survival rate was significantly lower in patients with LVDD than in those without LVDD (31.1 months vs. 42.6 months, P=0.01). In a multivariate analysis, the Child-Pugh score and LVDD were independent predictors of survival. Moreover, patients with a ratio of early filling velocity to early diastolic mitral annular velocity (E/e') ${\geq}10$ (LVDD grade 2) had lower survival than patients with E/e' ratio < 10. Conclusions: The presence of LVDD is associated with poor survival in patients with decompensated LC. Therefore, it may be important to monitor and closely follow LVDD patients.

• Applied Microscopy
• /
• 제27권2호
• /
• pp.121-130
• /
• 1997

It has been demonstrated that majority of cells in the mammalian body such as myocytes and epithelial cells of skin and intestine respond to mechanical force or environmental factors and exhibit partial disruption of cell membrane, i. e., cell wounding, even in a physiological condition. Myocardial cells are rather apt to be wounded than other cells since they are definitely exposed to mechanical stress by contraction-relaxation and blood flow. However, the mechanism how myocardial cells protect themselves against cell wounding is not yet clarified. On this background, the present study was performed to elucidate whether albumin leakage is related to cell wounding and to assess whether diltiazem, a potent calcium channel blocker, is beneficial in isoproterenol-induced cell wounding in the heart. Hearts isolated from New Zealand White rabbits ($1.5\sim2.0kg$ body weight, n=20) were perfused with Tyrode solution by Langendorff technique. After stabilization of baseline hemodynamics, the hearts were subjected to bolus administration of isoproterenol and diltiazem as following order: $1.6{\mu}M$ isoproterenol at zero min (the beginning point): $16{\mu}M$ diltiazem at 20min; $1.6{\mu}M$ isoproterenol at 25min; $16{\mu}M$ isoproterenol at 45 min; $160{\mu}M$ diltiazem at 65 min; $16{\mu}M$ isoproterenol at 70 min. During all experiments, the left ventricular function was recorded, albumin leakage in the coronary effluents was analyzed by electrophoresis and Western blot, and myocardial cell membranes were examined by conventional transmission electron microscopy. Data were analyzed by t-test and linear regression test. Isoproterenol significantly increased the inotropic and chronotropic contractions, coronary flow, and frequency of arrhythmia, however, diltiazem did not influence on hemodynamics except decrease in the frequency of arrhythmia and a slight decrease in contractility. Isoproterenol also resulted partial disruption of myocardial cell membrane and inclose in albumin leakage, while diltiazem pretreatment showed number of electron-dense plaques in the cell membrane and a tendency of decrease in albumin leakage. These results indicate that albumin leakage may be an indirect index of cell wounding in the heart and diltiazem nay be beneficial to protect myocardial cells against isoproterenol-induced cell wounding. It is likely that diltiazem promotes resealing process of the cell membrane.

• Journal of Chest Surgery
• /
• 제30권1호
• /
• pp.1-10
• /
• 1997

심장이식 수술의 성공의 관건은 공여자와 수혜자의 적절한 조합과 이미 정립된 수술수기와 합께 적출된 심장의 효과적인 기능 보존에 달려있다. 심장 보존에 있어서 괄목할 만한 발전이 있었음에도 불구하고 최근의 가장 진보된 방법으로 심 허 혈 상태의 최대 허용기간은 약 4~6시간정도이다 저자는 이식을 위한 적출 심장의 보존 용액 이 갖추어야 할 적정 요건에 대한 자료를 축적하고자, 단순 저온 침적방법에 의거하여, H/S용액(I군)을 대조군으로 하여 저자가 고안한 CK용액(W군)을 기존의 MEC용액( ll군) 및 MUW용액(E군)과 비교 실험하였다. 적출된 가토의 심장을 실험 대상으로 하고 정압형 Langendorff실험모형을 사용하여, 20분간의 평형 상태, 4시간동안의 심장 저장 및 20분간의 재관류시기를 거치게 한 후, 심근 조직을 절제하여 냉동 보관하였다. 실험 계획에 따라 관관류량,좌심실압, 압력 미분치를 측정하였고, 동결 심근조직내의 효소치를 정량 분석하였다. 결론적으로, 저자의 비교 실험에서 MUW용액과 CK용액의 심근보호 능력이 우수하였고, MEC용액은 대조군에 비해 저조하였다. potassium의 농도가 MVW용액보다 낮고()4.2nM/L), 문헌상에서 \ulcorner\ulcorner보호에 유익한 것으로 보고된 각종의 substrate을 첨가하여 제작된 CK용액의 성적이 MUW용액 과 비슷한 수준으로 우수하였는데, 이는 심장보존용액의 전해질 농도의 조정과 첨가물질의 선택 및 조정에 있어서 지속적인 연구와 발전이 필요함을 시사한다고 할 수 있다.

• 핵의학기술
• /
• 제14권2호
• /
• pp.150-154
• /
• 2010

심장기능을 평가하는데 중요한 기준이 되는 심박출계수의 측정은 반복검사가 용이한 심초음파가 가장 흔히 사용되고 있다. 현재 게이트심장혈액풀스캔의 검사 빈도가 낮고 게이트심장혈액풀 SPECT를 이용한 좌심실 심박출계수의 결과는 게이트심장혈액풀스캔과 심초음파의 결과와 비교적 잘 맞는 것으로 알려져 있으나 임상적으로는 잘 이용되지 못하고 있다. 이에 본 연구에서는 게이트심장혈액풀스캔 및 SPECT에서의 심박출계수를 심초음파와 비교하여 분석하였다. 2007년 1월부터 2010년 5월까지 34명의 환자를 대상으로 심초음파 검사 후 게이트심장혈액풀스캔과 SPECT를 함께 시행하였다. 대상 환자 가운데 남자가 23명이었고 여자는 11명이었으며 평균연령은 $52.6{\pm}27.2$세였다. 환자에게 생리식염수로 희석한 pyrophosphate 1 cc를 먼저 정맥주사하고 15분 후 20 mCi의 $^{99m}{TcO_4}^-$를 정맥주사 하였다. 10분 후 안정 상태에서 심전도를 부착한 뒤 planar와 SPECT를 연속하여 촬영하고 ADAC Laboratories, Ver. 4.20 software를 이용하여 영상을 분석하고 각각의 심박출계수를 측정하였다. 일원배치 분산분석(one-way anova) 후 사후검정(Tukey test)을 통해 평균값을 비교하고 서로 간 pearson 상관계수를 구하였다(SPSS Ver 17.0). 심박출계수의 평균값과 표준편차값은 planar에서 $56.3{\pm}13.9$ (%), SPECT에서 $60.4{\pm}16.0$ (%), 심초음파에서는 $59.1{\pm}14.4$ (%)로 유의한 차이는 없었으며(p=0.486) 이에 대한 사후 검정은 planar-심초음파 p=0.697, SPECT-심초음파 p=0.928, planar-SPECT p=0.469로 유의한 차이가 없었다. 상관관계에서는 planar-심초음파 r=0.801, SPECT-심초음파 r=0.810, planar-SPECT r=0.873 비교적 높은 상관관계를 보였다(p<0.01). 게이트혈액풀스캔 및 SPECT와 심초음파를 이용하여 구한 좌심실의 심박출계수는 높은 상관성을 보였으며 평균값에서도 유의한 차이는 없었다. 현재 게이트혈액풀스캔은 시행건수가 줄어들고 스캔의 정확성이나 재현성에 대한 문제는 남아있으며 SPECT의 경우 임상적으로 잘 적용되지 못하고 있으나 다양한 심기능 지표들을 얻을 수 있고 혈액풀스캔에서의 심박출계수와 좋은 일치율을 보이므로 심초음파를 대체할 수 있는 유용한 검사법이라 생각된다.

• Journal of Chest Surgery
• /
• 제40권9호
• /
• pp.593-599
• /
• 2007

배경: 폐절제술이 우심실 기능에 미치는 영향과 BNP (brain natriuretic peptide)의 관계에 대해서는 아직 자세히 알려져 있지 않다. 본 연구에서는 폐절제술 후 변화하는 혈역학적 수치와 우심부전의 보상기전으로서 증가하는 BNP의 관계에 대해서 알아보고 BNP가 폐절제술 후의 우심부전의 지표가 될 수 있는지를 확인하고자 하였다. 대상 및 방법: 폐암으로 폐엽절제술과 전폐절제술을 시행한 12명의 환자에서 면역화학적 방법(Elecsys $1010^{(R)}$, Roche, Germany)을 이용하여 수술 전후의 NT-proBNP 수준을 측정하고, Swan-Ganz 카테터로 수술 전후에 혈역학적 지표를 측정하여 비교하였으며 수술 전후에 심초음파를 시행하여 우심실 및 좌심실압 등의 변화를 비교하였다. 통계처리는 SPSSWIN(version 11.5)를 이용한 Wilcoxon rank sum test와 linear regression을 이용하였다. 결과: NT-proBNP 수준은 수술 전과 비교하여 수술 후 6시간, 수술 후 1일과 2일, 3일, 7일째에 유의하게 증가하였다(p=0.003, 0.002, 0.002, 0.006, 0.004). Swan-Ganz 카테터를 통한 혈역학적 변수 중에서는 평균 폐동맥압이 수술 전과 비교하여 수술 직후와 수술 후 6시간, 수술 후 1일, 2일, 3일째에 유의하게 증가하였으며(p=0.002, 0.002, 0.006, 0.007, 0.008), 평균 우심실압력은 수술 직후와 수술 후 6시간, 수술 후 1일과 3일에서 유의하게 증가하였다(p=0.006, 0.009, 0.044, 0.032). 폐혈관저항지수[폐혈관저항지수=(평균폐동맥압-평균폐동맥쐐기압)/심박출계수]는 수술 후 6시간, 수술 후 2일에서 유의한 증가가 있었다(p=0.008, 0.028). 평균폐동맥압의 수술 후 변화와 NT-proBNP 변화를 회기분석하였을 때 수술 후 6시간에서 유의성이 있었으며(r=0.602, p=0.038) 이후에는 유의성이 없었다. 심초음파 결과는 수술 전후를 비교하여 유의성이 없었다. 결론: 폐절제술 후 6시간의 폐동맥압의 변화와 NT-proBNP의 변화가 유의성이 있었다. 따라서 폐절제술 후 NT-proBNP의 변화는 폐절제술 후 우심실의 조기 혈역학적 변화를 반영하는 척도가 될 수 있으리라 판단된다.

• Journal of Cardiovascular Imaging
• /
• 제31권3호
• /
• pp.125-132
• /
• 2023

BACKGROUND: There is limited data on the residual echocardiographic findings including strain analysis among post-coronavirus disease (COVID) patients. The aim of our study is to prospectively phenotype post-COVID patients. METHODS: All patients discharged following acute COVID infection were systematically followed in the post-COVID-19 Recovery Clinic at Vancouver General Hospital and St. Paul's Hospital. At 4-18 weeks post diagnosis, patients underwent comprehensive echocardiographic assessment. Left ventricular ejection fraction (LVEF) was assessed by 3D, 2D Biplane Simpson's, or visual estimate. LV global longitudinal strain (GLS) was measured using a vendor-independent 2D speckle-tracking software (TomTec). RESULTS: A total of 127 patients (53% female, mean age 58 years) were included in our analyses. At baseline, cardiac conditions were present in 58% of the patients (15% coronary artery disease, 4% heart failure, 44% hypertension, 10% atrial fibrillation) while the remainder were free of cardiac conditions. COVID-19 serious complications were present in 79% of the patients (76% pneumonia, 37% intensive care unit admission, 21% intubation, 1% myocarditis). Normal LVEF was seen in 96% of the cohort and 97% had normal right ventricular systolic function. A high proportion (53%) had abnormal LV GLS defined as < 18%. Average LV GLS of septal and inferior segments were lower compared to that of other segments. Among patients without pre-existing cardiac conditions, LVEF was abnormal in only 1.9%, but LV GLS was abnormal in 46% of the patients. CONCLUSIONS: Most post-COVID patients had normal LVEF at 4-18 weeks post diagnosis, but over half had abnormal LV GLS.